Search Results for: Bio pharmaceutical

The Risk of Respiratory Tract Infections in Psoriasis Patients Treated With IL-23-pathway Inhibiting Biologics: A Meta-Estimate of Pivotal Trials Relevant to Decision-Making During the COVID-19 Pandemic.

The Risk of Respiratory Tract Infections in Psoriasis Patients Treated With IL-23-pathway Inhibiting Biologics: A Meta-Estimate of Pivotal Trials Relevant to Decision-Making During the COVID-19 Pandemic.

Coronavirus Literature
Publication date: Jul 02, 2020 Concepts Keywords Psoriasis Psoriasis Autoimmune diseases RTT Health Life sciences Organ systems Respiratory tract infection Biopharmaceutical Semantics Type Source Name disease MESH Respiratory Tract Infections ... Read more